| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.68B | 5.57B | 5.48B | 4.98B | 4.67B | 4.80B |
| Gross Profit | 2.00B | 2.09B | 2.04B | 1.80B | 1.75B | 1.76B |
| EBITDA | 769.00M | 839.00M | 866.00M | 778.00M | 837.00M | 821.25M |
| Net Income | 249.00M | 319.00M | 367.00M | 348.00M | 422.00M | 428.00M |
Balance Sheet | ||||||
| Total Assets | 4.01B | 4.01B | 3.63B | 3.56B | 3.64B | 3.36B |
| Cash, Cash Equivalents and Short-Term Investments | 172.00M | 217.00M | 182.00M | 237.00M | 173.00M | 218.00M |
| Total Debt | 2.48B | 2.57B | 2.27B | 2.25B | 2.27B | 2.03B |
| Total Liabilities | 3.30B | 3.25B | 4.36B | 4.28B | 2.89B | 2.63B |
| Stockholders Equity | 711.00M | 752.00M | 926.22M | -720.00M | 746.00M | 733.00M |
Cash Flow | ||||||
| Free Cash Flow | 513.00M | 544.00M | 623.00M | 689.00M | 395.00M | 740.00M |
| Operating Cash Flow | 646.00M | 675.00M | 746.00M | 782.00M | 491.00M | 827.00M |
| Investing Cash Flow | -121.00M | -254.00M | -118.00M | -87.00M | -85.00M | -70.00M |
| Financing Cash Flow | -544.00M | -384.00M | -680.00M | -634.00M | -450.00M | -969.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.59B | 8.95 | 10.71% | 1.62% | 0.50% | 20.52% | |
74 Outperform | £30.09B | 7.58 | 13.57% | 3.25% | 1.05% | -20.25% | |
71 Outperform | £7.28B | 14.67 | 17.98% | 3.56% | 1.92% | 0.50% | |
70 Outperform | £7.63B | 11.60 | 5.08% | 4.02% | 0.82% | 160.81% | |
66 Neutral | £1.74B | 12.40 | 34.27% | 17.38% | 1.74% | -23.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
52 Neutral | £1.54B | 3.62 | 24.47% | ― | ― | ― |